Under the terms of the deal, Merck will gain the exclusive global license to develop, manufacture and commercialize Hansoh Pharma's HS-10535, an experimental oral drug that targets a gut hormone called GLP-1
Ya BL, Liu Q, Li HF et al
For example, Tesamorelin may help reduce deep belly fat (visceral fat) while preserving lean mass, and Tesofensine can suppress appetite and increase energy expenditure
Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA et al
Benefits of GLP-1 Weight Loss Therapy Proven weight loss (average of 1520% body weight over 612 months) Decreased appetite and food cravings Improved blood sugar and insulin sensitivity Support for long-term behavior change Boosted confidence and mental well-being